Los Angeles Capital Management’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Buy |
+19,715
| New | +$224K | ﹤0.01% | 1151 |
|
|
2025
Q1 | – | Sell |
-43,438
| Closed | -$479K | – | 1219 |
|
|
2024
Q4 | $479K | Sell |
43,438
-59,567
| -58% | -$657K | ﹤0.01% | 823 |
|
|
2024
Q3 | $1.27M | Buy |
103,005
+36,240
| +54% | +$445K | 0.01% | 571 |
|
|
2024
Q2 | $902K | Buy |
66,765
+4,508
| +7% | +$60.9K | ﹤0.01% | 686 |
|
|
2024
Q1 | $840K | Hold |
62,257
| – | – | ﹤0.01% | 746 |
|
|
2023
Q4 | $327K | Buy |
62,257
+14,510
| +30% | +$76.3K | ﹤0.01% | 990 |
|
|
2023
Q3 | $188K | Sell |
47,747
-1,330
| -3% | -$5.24K | ﹤0.01% | 1073 |
|
|
2023
Q2 | $522K | Buy |
49,077
+10,022
| +26% | +$107K | ﹤0.01% | 843 |
|
|
2023
Q1 | $325K | Sell |
39,055
-1,358
| -3% | -$11.3K | ﹤0.01% | 988 |
|
|
2022
Q4 | $373K | Buy |
40,413
+12,190
| +43% | +$113K | ﹤0.01% | 974 |
|
|
2022
Q3 | $362K | Hold |
28,223
| – | – | ﹤0.01% | 1024 |
|
|
2022
Q2 | $373K | Buy |
28,223
+5,210
| +23% | +$68.9K | ﹤0.01% | 1076 |
|
|
2022
Q1 | $484K | Buy |
23,013
+4,410
| +24% | +$92.7K | ﹤0.01% | 1046 |
|
|
2021
Q4 | $446K | Sell |
18,603
-1,484
| -7% | -$35.6K | ﹤0.01% | 1062 |
|
|
2021
Q3 | $511K | Buy |
20,087
+2,970
| +17% | +$75.6K | ﹤0.01% | 1034 |
|
|
2021
Q2 | $576K | Buy |
+17,117
| New | +$576K | ﹤0.01% | 1115 |
|